Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, May 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 111 articles:
HTML format


 

Single Articles

  1. YANG K, Wang J, Lu W
    BMP signaling in pulmonary hypertension: advances and therapeutic implications.
    Exp Physiol. 2017 Apr 27. doi: 10.1113/EP086041.
    Abstract    

    Abstract available

  2. MIAO R, Leng D, Wang Y, Li JF, et al
    [Differentially expressed genes analysis in expression profile data of pulmonary fibrosis with pulmonary hypertension].
    Zhonghua Yi Xue Za Zhi. 2017;97:1240-1243.
    Abstract    

    Abstract available

  3. RICHTER MJ, Gall H, Wittkaemper G, Seeger W, et al
    EXPRESS: Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2017 Jan 1:2045893217709763. doi: 10.1177/2045893217709763.
    Abstract    



  4. SIKACHI RR, Sahni S, Mehta D, Agarwal A, et al
    Nationwide trends in inpatient admissions of pulmonary hypertension in the United States from 2000 to 2013.
    Adv Respir Med. 2017;85:77-86.
    Abstract    

    Abstract available

  5. GUTMANN A, Kaier K, Reinecke H, Frankenstein L, et al
    Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement.
    EuroIntervention. 2017 Apr 25. pii: EIJ-D-16-00927. doi: 10.4244/EIJ-D-16-00927.
    Abstract    

    Abstract available

  6. ZHUO Y, Zeng Q, Zhang P, Li G, et al
    VEGF Promoter Polymorphism Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese Population.
    Yonsei Med J. 2017;58:305-311.
    Abstract    

    Abstract available

  7. CRAWFORD NF, Thomas MG, Holt TN, Speidel SE, et al
    Heritabilities and genetic correlations of pulmonary arterial pressure and performance traits in Angus cattle at high altitude.
    J Anim Sci. 2016;94:4483-4490.
    Abstract    

    Abstract available

  8. LU Z, Li S, Zhao S, Fa X, et al
    Upregulated miR-17 Regulates Hypoxia-Mediated Human Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis by Targeting Mitofusin 2.
    Med Sci Monit. 2016;22:3301-8.
    Abstract    

    Abstract available

  9. ROTH P
    Pulse Oximetry and the Neonate.
    Pediatr Rev. 2016;37:402-5.
    Abstract    



  10. BURGER CD, D'Albini L, Raspa S, Pruett JA, et al
    The evolution of prostacyclins in pulmonary arterial hypertension: from classical treatment to modern management.
    Am J Manag Care. 2016;22.
    Abstract    

    Abstract available

  11. KHAN MA, Ho AC, Spirn MJ
    COTTON-WOOL SPOTS AFTER USE OF MACITENTAN FOR PULMONARY ARTERIAL HYPERTENSION.
    Retin Cases Brief Rep. 2017;11:4-6.
    Abstract    

    Abstract available

  12. OZKECECI G, Ulasli SS, Akci O, Dural IE, et al
    Assessment of pulmonary arterial stiffness in obstructive sleep apnea.
    Int J Cardiovasc Imaging. 2016;32:799-805.
    Abstract    

    Abstract available

  13. LEE Y, Choi W, Lee D, Chang J, et al
    Correlation between caudal pulmonary artery diameter to body surface area ratio and echocardiography-estimated systolic pulmonary arterial pressure in dogs.
    J Vet Sci. 2016;17:243-51.
    Abstract    

    Abstract available

  14. ROGERS NM, Ghimire K, Calzada MJ, Isenberg JS, et al
    Matricellular Protein Thrombospondin-1 in Pulmonary Hypertension: Multiple Pathways to Disease.
    Cardiovasc Res. 2017 May 4. doi: 10.1093.
    Abstract    

    Abstract available


  15. Erratum: Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates.
    Ann Thorac Med. 2017;12:131.
    Abstract    

    Abstract available


  16. Erratum: Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: Pulmonary hypertension due to left heart disease.
    Ann Thorac Med. 2017;12:130.
    Abstract    

    Abstract available

  17. ASCHA M, Renapurkar RD, Tonelli AR
    A review of imaging modalities in pulmonary hypertension.
    Ann Thorac Med. 2017;12:61-73.
    Abstract    

    Abstract available

  18. MARSBOOM G, Chen Z, Yuan Y, Zhang Y, et al
    Aberrant caveolin-1-mediated Smad signaling and proliferation identified by analysis of adenine 474 deletion mutation (c.474delA) in patient fibroblasts: a new perspective on the mechanism of pulmonary hypertension.
    Mol Biol Cell. 2017;28:1177-1185.
    Abstract    

    Abstract available

  19. BALLOUT FA, Manshad AS, Okwuosa TM
    Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.
    Curr Treat Options Cardiovasc Med. 2017;19:44.
    Abstract    

    Abstract available

  20. PATIL RK, Goyal P, Swaminathan RV, Kim LK, et al
    Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension.
    Curr Treat Options Cardiovasc Med. 2017;19:40.
    Abstract    

    Abstract available

  21. PALAZZINI M, Dardi F, Manes A, Bacchi Reggiani ML, et al
    Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
    Eur J Heart Fail. 2017 May 2. doi: 10.1002.
    Abstract    

    Abstract available

  22. ZHOU T, Tang H, Han Y, Fraidenburg D, et al
    Expression profile of mitochondrial voltage-dependent anion channel-1 (VDAC1) influenced genes is associated with pulmonary hypertension.
    Korean J Physiol Pharmacol. 2017;21:353-360.
    Abstract    

    Abstract available

  23. PULLAMSETTI SS, Savai R
    Macrophage Regulation during Vascular Remodeling: Implications for Pulmonary Hypertension Therapy.
    Am J Respir Cell Mol Biol. 2017;56:556-558.
    Abstract    



  24. LIAN TY, Jiang X, Jing ZC
    Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
    Drug Des Devel Ther. 2017;11:1195-1207.
    Abstract    

    Abstract available

  25. TSUCHIYA H, Kioka H, Ozu K, Ohtani T, et al
    Interferon Therapy Exacerbated Pulmonary Hypertension in a Patient with Hepatitis C Virus Infection: Pathogenic Interplay among Multiple Risk Factors.
    Intern Med. 2017;56:1061-1065.
    Abstract    

    Abstract available

  26. QUEZADA LOAIZA CA, Velazquez Martin MT, Jimenez Lopez-Guarch C, Ruiz Cano MJ, et al
    Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre.
    Rev Esp Cardiol (Engl Ed). 2017 Apr 25. pii: S1885-5857(17)30175.
    Abstract    

    Abstract available

  27. XUE C, Sowden M, Berk BC
    Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.
    Arterioscler Thromb Vasc Biol. 2017 Apr 27. pii: ATVBAHA.117.309212.
    Abstract    

    Abstract available

  28. AHMED LA, Rizk SM, El-Maraghy SA
    Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats.
    Biochem Pharmacol. 2017 Apr 24. pii: S0006-2952(17)30241.
    Abstract    

    Abstract available

  29. ALMENEESSIER AS, Nashwan SZ, Al-Shamiri MQ, Pandi-Perumal SR, et al
    The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study.
    J Thorac Dis. 2017;9:779-788.
    Abstract    

    Abstract available

  30. MA Y, Jang MA, Yoo HS, Ahn SY, et al
    A Novel De Novo Pathogenic Variant in FOXF1 in a Newborn with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins.
    Yonsei Med J. 2017;58:672-675.
    Abstract    

    Abstract available

  31. HOMSI R, Luetkens JA, Skowasch D, Pizarro C, et al
    Left Ventricular Myocardial Fibrosis, Atrophy, and Impaired Contractility in Patients With Pulmonary Arterial Hypertension and a Preserved Left Ventricular Function: A Cardiac Magnetic Resonance Study.
    J Thorac Imaging. 2017;32:36-42.
    Abstract    

    Abstract available

  32. SZAFRANSKI P, Herrera C, Proe LA, Coffman B, et al
    Narrowing the FOXF1 distant enhancer region on 16q24.1 critical for ACDMPV.
    Clin Epigenetics. 2016;8:112.
    Abstract    

    Abstract available

  33. LEE JJ, Pope JE
    Emerging drugs and therapeutics for systemic sclerosis.
    Expert Opin Emerg Drugs. 2016;21:421-430.
    Abstract    

    Abstract available

  34. BARNETT CF, De Marco T
    Treatment of advanced group 2 PH.
    Prog Cardiovasc Dis. 2016;59:78-86.
    Abstract    

    Abstract available

  35. KUBBA S, Davila CD, Forfia PR
    Methods for Evaluating Right Ventricular Function and Ventricular-Arterial Coupling.
    Prog Cardiovasc Dis. 2016;59:42-51.
    Abstract    

    Abstract available

  36. GUAZZI M, Labate V
    Group 2 PH: Medical Therapy.
    Prog Cardiovasc Dis. 2016;59:71-7.
    Abstract    

    Abstract available

  37. LV Y, Han G, Fan D
    Portopulmonary hypertension.
    Scand J Gastroenterol. 2016;51:795-806.
    Abstract    

    Abstract available

  38. SU B, Tan RS, Tan JL, Guo KW, et al
    Cardiac MRI based numerical modeling of left ventricular fluid dynamics with mitral valve incorporated.
    J Biomech. 2016;49:1199-205.
    Abstract    

    Abstract available

  39. FENSTER BE, Lasalvia L, Schroeder JD, Smyser J, et al
    Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.
    Heart Vessels. 2016;31:939-46.
    Abstract    

    Abstract available

  40. PETERSEN J, Pecha S, Neumann N, Conradi L, et al
    Uncommon cause of pulmonary hypertension.
    J Card Surg. 2017 May 11. doi: 10.1111/jocs.13144.
    Abstract    



  41. HAYATI F, Beladi Mousavi SS, Mousavi Movahed SM, Mofrad Bushehri M, et al
    Pulmonary hypertension among patients undergoing hemodialysis.
    J Renal Inj Prev. 2016;6:122-126.
    Abstract    

    Abstract available

  42. IMOTO K, Okada M, Yamawaki H
    Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats.
    J Vet Med Sci. 2017 May 11. doi: 10.1292/jvms.17-0053.
    Abstract    

    Abstract available

  43. LUECKE C, McPherson C
    Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates.
    Neonatal Netw. 2017;36:160-168.
    Abstract    

    Abstract available

  44. UNAL S, Aktas S, Aksu M, Hirfanoglu IM, et al
    Iloprost Instillation in Two Neonates with Pulmonary Hypertension.
    J Coll Physicians Surg Pak. 2017;27:257-259.
    Abstract    

    Abstract available

  45. ORMENO JULCA AJ, Alvarez Murillo CM, Amoretti Alvino PM, Florian Florian AA, et al
    [Clinical and laboratory characteristics of patients with pulmonary hypertension and pulmonary vascular complications hospitalized at the Instituto Nacional de Salud del Nino].
    Rev Gastroenterol Peru. 2017;37:9-15.
    Abstract    

    Abstract available

  46. BACZYNSKI M, Ginty S, Weisz DE, McNamara PJ, et al
    Short-term and long-term outcomes of preterm neonates with acute severe pulmonary hypertension following rescue treatment with inhaled nitric oxide.
    Arch Dis Child Fetal Neonatal Ed. 2017 May 8. pii: fetalneonatal-2016-312409.
    Abstract    

    Abstract available

  47. HAYES D JR, Tumin D, Budev MM, Tobias JD, et al
    Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
    Respir Med. 2017 Apr 22. pii: S0954-6111(17)30127.
    Abstract    

    Abstract available

  48. MA X, Yao J, Yue Y, Du S, et al
    Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.
    Interact Cardiovasc Thorac Surg. 2017 May 4. doi: 10.1093.
    Abstract    

    Abstract available

  49. LILJE C, Harry J, Gajewski KK, Gardner RV, et al
    A modified noninvasive screening protocol for pulmonary hypertension in children with sickle cell disease-Who should be sent for invasive evaluation?
    Pediatr Blood Cancer. 2017 May 5. doi: 10.1002/pbc.26606.
    Abstract    

    Abstract available

  50. ALIOTTA JM, Pereira M, Wen S, Dooner MS, et al
    Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.
    Stem Cells Transl Med. 2017 May 5. doi: 10.1002/sctm.16-0386.
    Abstract    

    Abstract available

  51. PINTALHAO M, Castro-Chaves P, Bettencourt P
    Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure? A reply.
    Eur J Heart Fail. 2017 May 4. doi: 10.1002.
    Abstract    



  52. ROIK M, Wretowski D, Labyk A, Irzyk K, et al
    Refined balloon pulmonary angioplasty-A therapeutic option in very elderly patients with chronic thromboembolic pulmonary hypertension.
    J Interv Cardiol. 2017 May 5. doi: 10.1111/joic.12387.
    Abstract    

    Abstract available

  53. SIRAJUDDIN A, Donnelly EF, Crabtree TP, Henry TS, et al
    ACR Appropriateness Criteria(R) Suspected Pulmonary Hypertension.
    J Am Coll Radiol. 2017;14.
    Abstract    

    Abstract available

  54. VAN RIEL AC, Opotowsky AR, Santos M, Rivero JM, et al
    Accuracy of Echocardiography to Estimate Pulmonary Artery Pressures With Exercise: A Simultaneous Invasive-Noninvasive Comparison.
    Circ Cardiovasc Imaging. 2017;10.
    Abstract    

    Abstract available

  55. LEE H, Kim KC, Choi SJ, Hong YM, et al
    Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.
    Yonsei Med J. 2017;58:570-580.
    Abstract    

    Abstract available

  56. SCHAFER M, Ivy DD, Abman SH, Barker AJ, et al
    Apparent Aortic Stiffness in Children With Pulmonary Arterial Hypertension: Existence of Vascular Interdependency?
    Circ Cardiovasc Imaging. 2017;10.
    Abstract    

    Abstract available

  57. ZIMMER A, Teixeira RB, Bonetto JH, Siqueira R, et al
    Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension.
    Mol Cell Biochem. 2017;429.
    Abstract    

    Abstract available

  58. BARBER NJ, Ako EO, Kowalik GT, Cheang MH, et al
    Magnetic Resonance-Augmented Cardiopulmonary Exercise Testing: Comprehensively Assessing Exercise Intolerance in Children With Cardiovascular Disease.
    Circ Cardiovasc Imaging. 2016;9.
    Abstract    

    Abstract available

  59. MATSUURA H
    Cardiac catheterization in children with pulmonary arterial hypertension.
    Pediatr Int. 2017;59:3-9.
    Abstract    

    Abstract available

  60. LIU Y, Liu G, Zhang H, Wang J, et al
    MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3.
    Biochem Biophys Res Commun. 2016 Mar 30. pii: S0006-291X(16)30453.
    Abstract    

    Abstract available

  61. AMANO H, Abe S, Hirose S, Waku R, et al
    Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertension.
    Heart Vessels. 2017 May 19. doi: 10.1007/s00380-017-0991.
    Abstract    

    Abstract available

  62. TAMURA M, Yamada Y, Kawakami T, Kataoka M, et al
    Diagnostic accuracy of lung subtraction iodine mapping CT for the evaluation of pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: Correlation with perfusion SPECT/CT.
    Int J Cardiol. 2017 May 4. pii: S0167-5273(16)34320.
    Abstract    

    Abstract available

  63. ZHANG C, Liu Y, Qing E, Ma J, et al
    [Preoperative risk factors analysis of pulmonary hypertension crisis during perioperative period for caesarean section of woman with severe pulmonary hypertension].
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017;29:431-435.
    Abstract    

    Abstract available

  64. SEETHARAM K, Williams EE, Oswald E, Reddy R, et al
    A chronic thromboembolic pulmonary hypertension catch-22 situation: inferior vena caval filter plays a pivotal role in an unlikely situation.
    J Thorac Dis. 2017;9:E346-E348.
    Abstract    

    Abstract available

  65. GRIMMINGER J, Richter M, Tello K, Sommer N, et al
    Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension.
    Can Respir J. 2017;2017:8381653.
    Abstract    

    Abstract available

  66. VESELOVA TN, Demchenkova AY, Martynyuk TV, Danilov NM, et al
    [Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study].
    Ter Arkh. 2017;89:8-14.
    Abstract    

    Abstract available

  67. AN Z, Wang D, Yang G, Zhang WQ, et al
    Role of microRNA-130a in the pathogeneses of obstructive sleep apnea hypopnea syndrome-associated pulmonary hypertension by targeting the GAX gene.
    Medicine (Baltimore). 2017;96:e6746.
    Abstract    

    Abstract available

  68. THURBER KM, Williams BM, Bates RE, Frantz RP, et al
    Transition of Intravenous Treprostinil to Oral Therapy in a Patient with Functional Class IV Chronic Thromboembolic Pulmonary Hypertension.
    Pharmacotherapy. 2017 May 17. doi: 10.1002/phar.1951.
    Abstract    

    Abstract available

  69. ALLISON JD, Macedo FY, Hamzeh IR, Birnbaum Y, et al
    Correlation of right atrial enlargement on ECG to right atrial volume by echocardiography in patients with pulmonary hypertension.
    J Electrocardiol. 2017 Apr 22. pii: S0022-0736(17)30115.
    Abstract    

    Abstract available

  70. AMADI VN, Balogun MO, Akinola NO, Adebayo RA, et al
    Pulmonary hypertension in Nigerian adults with sickle cell anemia.
    Vasc Health Risk Manag. 2017;13:153-160.
    Abstract    

    Abstract available

  71. AGGARWAL M, Grady RM
    Glucocorticoids for treating paediatric pulmonary hypertension: a novel use for a common medication.
    Cardiol Young. 2017 May 16:1-3. doi: 10.1017/S1047951117000464.
    Abstract    

    Abstract available

  72. TALWAR A, Sahni S, Verma S, Khan SZ, et al
    Exercise tolerance improves after pulmonary rehabilitation in pulmonary hypertension patients.
    J Exerc Rehabil. 2017;13:214-217.
    Abstract    

    Abstract available

  73. LAMMI MR, Saketkoo LA, Gordon JK, Lauto P, et al
    Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.
    Respirology. 2017 May 12. doi: 10.1111/resp.13067.
    Abstract    

    Abstract available

  74. PUGLIESE SC, Kumar S, Janssen WJ, Graham BB, et al
    A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.
    J Immunol. 2017 May 12. pii: 1601692. doi: 10.4049/jimmunol.1601692.
    Abstract    

    Abstract available

  75. LAHERA V
    Nitric oxide: A possible new biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failure.
    Clin Investig Arterioscler. 2017;29:127-128.
    Abstract    



  76. LIMA-SEOLIN BG, Colombo R, Bonetto JH, Teixeira RB, et al
    Bucindolol improves right ventricle function in rats with pulmonary arterial hypertension through the reversal of autonomic imbalance.
    Eur J Pharmacol. 2016 Dec 20. pii: S0014-2999(16)30809.
    Abstract    

    Abstract available

  77. LI N, Yin J, Cai W, Liu J, et al
    Coupling Factor 6 Is Upregulated in Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    Am J Med Sci. 2016;352:631-636.
    Abstract    

    Abstract available

  78. HOUMES RJ, Ten Kate CA, Wildschut ED, Verdijk RM, et al
    Risk and relevance of open lung biopsy in pediatric ECMO patients: the Dutch experience.
    J Pediatr Surg. 2017;52:405-409.
    Abstract    

    Abstract available

  79. MATURA LA, Fargo J, Fritz JS, Smith KA, et al
    Slow-paced respiration therapy to treat symptoms in pulmonary arterial hypertension.
    Heart Lung. 2017;46:7-13.
    Abstract    

    Abstract available

  80. MA L, Chung WK
    The role of genetics in pulmonary arterial hypertension.
    J Pathol. 2017;241:273-280.
    Abstract    

    Abstract available

  81. MURAKAMI T, Nakazawa G, Horinouchi H, Torii S, et al
    Transcatheter closure of atrial septal defect protects from pulmonary edema: septal occluder device gradually reduces LR shunt.
    Heart Vessels. 2017;32:101-104.
    Abstract    

    Abstract available

  82. OGAWA A, Satoh T, Tamura Y, Fukuda K, et al
    Survival of Japanese Patients With Idiopathic/Heritable Pulmonary Arterial Hypertension.
    Am J Cardiol. 2017 Feb 9. pii: S0002-9149(17)30114.
    Abstract    

    Abstract available

  83. PATEL SG, Woolman P, Li L, Craft M, et al
    Relation of Right Atrial Volume, Systemic Venous Dimensions, and Flow Patterns to Right Atrial Pressure in Infants and Children.
    Am J Cardiol. 2017;119:1473-1478.
    Abstract    

    Abstract available

  84. BAZAN IS, Fares WH
    Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease.
    Am J Cardiol. 2016;117:1691-6.
    Abstract    

    Abstract available

  85. LARSEN CM, McCully RB, Murphy JG, Kushwaha SS, et al
    Usefulness of High-Density Lipoprotein Cholesterol to Predict Survival in Pulmonary Arterial Hypertension.
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30550.
    Abstract    

    Abstract available

  86. SORDELLI C, Lancellotti P, Carlomagno G, Di Giannuario G, et al
    Tricuspid Annular Size and Regurgitation Progression After Surgical Repair for Degenerative Mitral Regurgitation.
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30868.
    Abstract    

    Abstract available

  87. GLANCY DL, Aiello DC, Atluri P
    Electrocardiogram in a Young Woman With the Eisenmenger Syndrome.
    Am J Cardiol. 2016;118:305-6.
    Abstract    

    Abstract available

  88. HAECK ML, Hoogslag GE, Boden H, Velders MA, et al
    Prognostic Implications of Elevated Pulmonary Artery Pressure After ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30862.
    Abstract    

    Abstract available

  89. JORGE E, Pan M, Baptista R, Romero M, et al
    Predictors of Very Late Events After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis.
    Am J Cardiol. 2016 Apr 6. pii: S0002-9149(16)30438.
    Abstract    

    Abstract available


  90. Chronic Thromboembolic Pulmonary Hypertension: Part 1.
    Am J Respir Crit Care Med. 2017;195:P19-P20.
    Abstract    



  91. BOURGE RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, et al
    Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Chest. 2016;150:27-34.
    Abstract    

    Abstract available

  92. MATURA LA, Shou H, Fritz JS, Smith KA, et al
    Physical Activity and Symptoms in Pulmonary Arterial Hypertension.
    Chest. 2016;150:46-56.
    Abstract    

    Abstract available

  93. HUERTAS A, Phan C, Bordenave J, Tu L, et al
    Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.
    Chest. 2016;149:1482-93.
    Abstract    

    Abstract available

  94. ROSE JA, Cleveland JM, Rao Y, Minai OA, et al
    Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.
    Chest. 2016;149:1234-44.
    Abstract    

    Abstract available

  95. MAR PL, Nwazue V, Black BK, Biaggioni I, et al
    Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.
    Chest. 2016;149:1252-60.
    Abstract    

    Abstract available

  96. MEHARI A, Klings ES
    Chronic Pulmonary Complications of Sickle Cell Disease.
    Chest. 2016;149:1313-24.
    Abstract    

    Abstract available

  97. WELLS JM, Morrison JB, Bhatt SP, Nath H, et al
    Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.
    Chest. 2016;149:1197-204.
    Abstract    

    Abstract available

  98. RAEISI-GIGLOU P, Wang XF, Dakkak W, Bair N, et al
    Effect of Weight on Parenteral Prostacyclin Analogues Dosing in Pulmonary Hypertension.
    Chest. 2017;151:1189-1192.
    Abstract    



  99. MEHTA S, Sastry BK, Souza R, Torbicki A, et al
    Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
    Chest. 2017;151:106-118.
    Abstract    

    Abstract available

  100. JAIN S, Khera R, Girotra S, Badesch D, et al
    Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.
    Chest. 2017;151:90-105.
    Abstract    

    Abstract available

  101. AVIRAM G, Rozenbaum Z, Ziv-Baran T, Berliner S, et al
    Identification of Pulmonary Hypertension Caused by Left Heart Disease (World Health Organization Group 2) Based on Cardiac Chamber Volumes Derived from Chest CT.
    Chest. 2017 May 12. pii: S0012-3692(17)30917-0. doi: 10.1016/j.chest.2017.
    Abstract    

    Abstract available

  102. BEST DH, Sumner KL, Smith BP, Damjanovich-Colmenares K, et al
    EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.
    Chest. 2017;151:821-828.
    Abstract    

    Abstract available

  103. CHEN J, Sysol JR, Singla S, Zhao S, et al
    Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and is a Therapeutic Target in Pulmonary Arterial Hypertension.
    Circulation. 2017 Feb 15. pii: CIRCULATIONAHA.116.024557.
    Abstract    

    Abstract available

  104. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    Abstract    

    Abstract available

  105. RHODES CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, et al
    Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.024602.
    Abstract    

    Abstract available

  106. JOUNEAU S, Ballerie A, Kerjouan M, Demant X, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    Abstract    



  107. SANGES S, Prevotat A, Fertin M, Terriou L, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    Abstract    



  108. HANSMANN G
    Pulmonary Hypertension in Infants, Children, and Young Adults.
    J Am Coll Cardiol. 2017;69:2551-2569.
    Abstract    

    Abstract available

  109. BOTROS L, Aman J, Bogaard HJ, Vonk Noordegraaf A, et al
    Pulmonary hypertension with warm hands.
    Thorax. 2017 May 5. pii: thoraxjnl-2017-209982.
    Abstract    



  110. RAJARAM P, Parekh A, Fisher M, Kempker J, et al
    Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience.
    Transplant Proc. 2017;49:338-343.
    Abstract    

    Abstract available

  111. WANG X, Shults NV, Suzuki YJ
    Oxidative profiling of the failing right heart in rats with pulmonary hypertension.
    PLoS One. 2017;12:e0176887.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;